Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

INTEGRATE INTEGRATE - Interdisciplinary Network for Training, Education, and Growing Research into Applications of and Therapeutic Expertise around Psychedelics

Coordinator
Academisch Ziekenhuis Groningen, Netherlands
Runs
1 March 2026 to 28 February 2030
Status
Running
EU funding
€4.3m
Total cost
—
Partners
34 organisations in 12 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226862

What the project is doing

In the project's own words, from its summary on CORDIS.

Late-stage clinical trials show that psychedelic therapy (PT) has the potential to revolutionize mental disorder treatments, answering a huge and increasing unmet need. INTEGRATE is a multidisciplinary, multi-sectoral Doctoral Network (DN) for training and educating future leaders/experts in implementation of PT in society and healthcare. Four key challenges are identified: 1) The mechanisms of action of PT remain elusive, 2) Lack of clinical gold standards, 3) Legal, financial, and regulatory obstacles for PT access, and 4) Hype, hope, and ethical challenges.

Through interdisciplinary research, training, and collaboration, INTEGRATE aims to advance psychedelic science, optimize treatment protocols, and address ethical and regulatory challenges to improve mental healthcare. It addresses the urgent need for well-trained experts to navigate the complex landscape of PT in healthcare. The project will train 16 Doctoral Candidates (DCs) to become T-shaped professionals, equipped with deep disciplinary knowledge and broad interdisciplinary skills.

Through collaborative research, innovative training, and strategic secondments, INTEGRATE will tackle the key challenges in PT research with matching research and innovation objectives. The network brings together leading academic institutions, industry partners, and non-profit organizations across Europe, fostering a collaborative environment for advancing psychedelic science and improving mental healthcare.

Topics

Who is involved

OrganisationCityCountryRole
Academisch Ziekenhuis GroningenGroningenNetherlandsCoordinator
Monash UniversityVictoriaAustraliaAssociatedpartner
Reconnect Labs AGWinterthurSwitzerlandAssociatedpartner
Schweizerische Ärztegesellschaft für Psycholytische Therapie (SÄPT)BernSwitzerlandAssociatedpartner
Universitat BaselBaselSwitzerlandAssociatedpartner
Universitat ZurichZurichSwitzerlandAssociatedpartner
Narodni Ustav Dusevniho ZdraviKlecanyCzechiaParticipant
Univerzita KarlovaPraha 1CzechiaAssociatedpartner
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyAssociatedpartner
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Ecole Des Hautes Etudes En Sciences SocialesParisFranceAssociatedpartner
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
Universite Paris CiteParisFranceAssociatedpartner
MIND Landelijke Platform Psychische GezondheidAmersfoortNetherlandsAssociatedpartner
Rijksuniversiteit GroningenGroningenNetherlandsParticipant
Stichting Centre for Human Drug ResearchLeidenNetherlandsAssociatedpartner
Stichting Open: Onderzoek Naar De Psychedelische Ervaring NederlandAmsterdamNetherlandsAssociatedpartner
Universiteit LeidenLeidenNetherlandsParticipant
Universiteit MaastrichtMaastrichtNetherlandsAssociatedpartner
Avextra Portugal SAGrândolaPortugalAssociatedpartner
Fundacao D. Anna De Sommer Champalimaud E Dr. Carlos Montez ChampalimaudLisboaPortugalParticipant
Ispa CrlLisboaPortugalAssociatedpartner
Osmond Labs ABUppsalaSwedenAssociatedpartner
Stockholms UniversitetStockholmSwedenParticipant
Svenska kyrkan SolnaSolnaSwedenAssociatedpartner
Uppsala UniversitetUppsalaSwedenParticipant
Clerkenwell Clinics LimitedLondonUnited KingdomAssociatedpartner
Simon Geoffrey David RuffellBristolUnited KingdomAssociatedpartner
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomAssociatedpartner
The University of ExeterExeterUnited KingdomAssociatedpartner
Alithos Health, Inc.Newark, DelawareUnited StatesAssociatedpartner
Johns Hopkins UniversityBaltimoreUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI